Analytical Data
-
Gene name
C13orf1
- Application
-
Alternative Names
SPRYD7; C13orf1; CLLD6; SPRY domain-containing Protein 7; Chronic lymphocytic leukemia deletion region gene 6 Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5W111
-
Expression Region
1-196aa
-
AA Sequence
MATSVLCCLR CCRDGGTGHI PLKEMPAVQL DTQHMGTDVV IVKNGRRICG TGGCLASAPL HQNKSYFEFK IQSTGIWGIG VATQKVNLNQ IPLGRDMHSL VMRNDGALYH NNEEKNRLPA NSLPQEGDVV GITYDHVELN VYLNGKNMHC PASGIRGTVY PVVYVDDSAI LDCQFSEFYH TPPPGFEKIL FEQQIF
-
Molecular Weight
21.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C13orf1, also known as the "Chromosome 13 Open Reading Frame 1," is a protein-coding gene located on chromosome 13 and has gained attention in recent years due to its potential role in various biological processes and diseases. Research suggests that C13orf1 may be involved in cellular functions such as cell proliferation, differentiation, and apoptosis, which are crucial for maintaining normal physiological conditions. Notably, changes in expression levels of C13orf1 have been linked to several types of cancer, indicating its possible role as a biomarker or therapeutic target. Furthermore, studies have indicated that C13orf1 may interact with other key proteins and signaling pathways, highlighting its significance in cellular signaling networks. The recombinant protein studies of C13orf1 aim to elucidate its specific functions and interactions at the molecular level, providing insights that could pave the way for novel therapeutic strategies. Understanding the structure and function of C13orf1 may also contribute to the development of diagnostic tools for diseases associated with its dysregulation, thus reinforcing the importance of ongoing research in this area.
